Delivered as a Hybrid Event
September 27-30, 2022,
Boston Convention and Exhibition Center
Accelerate your bioprocessing, analytics, supply chain security and commercialization strategies by accessing novel science, technologies and the contacts you need.
Cell & Gene Therapy Manufacturing & Commercialization US features 5 conference tracks in Cell Therapy, Gene-Edited Ex Vivo Cell Therapy, In Vivo Gene Therapy, Cell and Gene Therapy – Partnering Track, and New Frontiers for Cell and Tissue Manufacturing: In collaboration with ARMI.
Join ARMI | BioFabUSA on Friday, September 30 at our New Frontiers for Cell and Tissue Manufacturing workshop.
Click here to register
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
